InsidersTradesSigma
Follow the 富士製薬工業株式会社 share price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 富士製薬工業株式会社 has published 12 insider filings. Market capitalisation: €48.1bn. The latest transaction was reported on 31 July 2026 (Holding update). Among the most active insiders: Hirofumi Imai. Every trade is free.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 富士製薬工業株式会社 Buy (bullish), based on 2 analysts. Average price target: JP¥3,000.
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,819 of 28,549 companies
56.3
score / 100
Value66
Quality47
FCF yld4.0%
Earn yld6.2%
EV/EBITDA9.5x
ROE6.1%
Gross mgn40%
Net mgn5.8%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 July 2026
Declarations12 total
1.11% mcap18.4% of flowShareXTKSEDINET:S100YOUW
1.07% mcap18.4% of flowShareXTKSEDINET:S100YINT
1.10% mcap18.4% of flowShareXTKSEDINET:S100Y809
1.09% mcap18.3% of flowShareXTKSEDINET:S100Y1TH
ShareXTKSEDINET:S100XRM5
ShareXTKSEDINET:S100XOM2
ShareXTKSEDINET:S100XMJA
19.5% of flowShareXTKSEDINET:S100XKIN
20.3% of flowShareXTKSEDINET:S100WI4S
100.0% of flowShareXTKSEDINET:S100U7L5
46.0% of flowShareXTKSEDINET:S100TBRL
100.0% of flowShareXTKSEDINET:S100Q1CO
12 of 12 declarations
关于 富士製薬工業株式会社
Fuji Pharma Co., Ltd. 是一家在日本医疗保健和制药领域运营的公司。它专注于药品的研发和营销。